{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:55:03Z","timestamp":1787500503851,"version":"build-2736575974"},"reference-count":169,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-025-03796-9","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:57:46Z","timestamp":1761721066000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The public health impact of making chloramphenicol an over-the-counter antibiotic: a systematic literature review"],"prefix":"10.1007","volume":"45","author":[{"given":"Chun Hin","family":"Yung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shing Chuen","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Buchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendrick Co","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"3796_CR1","unstructured":"American Academy of Ophthalmology Cornea\/External Disease Preferred Practice Panel (2023) Conjunctivitis. In: Cornea\/external disease preferred practice pattern. American Academy of Ophthalmology, pp 134\u2013204"},{"key":"3796_CR2","first-page":"78","volume":"17","author":"JE Schneider","year":"2014","unstructured":"Schneider JE, Scheibling CM, Segall D et al (2014) Epidemiology and economic burden of conjunctivitis: a managed care perspective. J Managed Care Med 17:78\u201383","journal-title":"J Managed Care Med"},{"key":"3796_CR3","first-page":"544","volume":"23","author":"T Shields","year":"1991","unstructured":"Shields T, Sloane PD (1991) A comparison of eye problems in primary care and ophthalmology practices. Fam Med 23:544\u2013546","journal-title":"Fam Med"},{"key":"3796_CR4","unstructured":"Joint Formulary Committee (2023) British National Formulary 85: March\u2013September 2023. Pharmaceutical Press, London"},{"key":"3796_CR5","unstructured":"Chloramphenicol (P medicine). Royal Pharmaceutical Society. https:\/\/link.springer.com\/journal\/10792\/submission-guidelines#Instructions%20for%20Authors_Text. Accessed 17 Sept 2025"},{"key":"3796_CR6","unstructured":"Chloromycetin 0.5% w\/v Redidrops eye drops, solution. Health Products Regulatory Authority. https:\/\/www.hpra.ie\/find-a-medicine\/for-human-use\/authorised-medicines\/details\/22730. Accessed 17 Sept 2025"},{"key":"3796_CR7","unstructured":"Therapeutic Goods (Poisons Standard\u2014June 2025) Instrument 2025. Federal Register of Legislation. https:\/\/www.legislation.gov.au\/F2025L00599\/asmade\/text. Accessed 17 Sept 2025."},{"key":"3796_CR8","unstructured":"Pharmacist-Only Medicines. New Zealand Medicines and Medical Devices Safety Authority. https:\/\/www.medsafe.govt.nz\/consumers\/pharmonly.asp. Accessed 17 Sept 2025"},{"key":"3796_CR9","unstructured":"Classification Database. New Zealand Medicines and Medical Devices Safety Authority. https:\/\/www.medsafe.govt.nz\/profs\/class\/classintro.asp. Accessed 17 September 2025."},{"key":"3796_CR10","unstructured":"Drugs@FDA: FDA-Approved Drugs. U.S. Food and Drug Administration. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm. Accessed 17 September 2025."},{"key":"3796_CR11","unstructured":"Drug Product Database online query. Government of Canada. https:\/\/health-products.canada.ca\/dpd-bdpp\/. Accessed 17 September 2025."},{"key":"3796_CR12","unstructured":"Optivis Ophthalmic Ointment 1%. Pharmacy & Poisons Board of Hong Kong. https:\/\/www.drugoffice.gov.hk\/eps\/drug\/productDetail2\/en\/consumer\/40482. Accessed 17 September 2025."},{"key":"3796_CR13","unstructured":"Chloramphenicol. In: National Drug Formulary. https:\/\/www.ndf.gov.sg\/monograph\/detail\/M00081. Accessed 17 September 2025."},{"key":"3796_CR14","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.7326\/0003-4819-33-6-1459","volume":"33","author":"ML Rich","year":"1950","unstructured":"Rich ML, Ritterhoff RJ, Hoffmann RJ (1950) A fatal case of aplastic anemia following chloramphenicol (chloromycetin) therapy. Ann Intern Med 33:1459\u20131467","journal-title":"Ann Intern Med"},{"key":"3796_CR15","volume-title":"Rodak\u2019s hematology: clinical principles and applications","author":"EM Keohane","year":"2020","unstructured":"Keohane EM, Otto CN, Walenga JM (2020) Rodak\u2019s hematology: clinical principles and applications. Elsevier, St. Louis"},{"issue":"6","key":"3796_CR16","first-page":"761","volume":"97","author":"JM Sutherland","year":"1959","unstructured":"Sutherland JM (1959) Fatal cardiovascular collapse of infants receiving large amounts of chloramphenicol. AMA J Dis Child 97(6):761\u2013767","journal-title":"AMA J Dis Child"},{"key":"3796_CR17","unstructured":"Bennett JE., Dolin Raphael, Blaser MJ. (2020) Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases, vol. 2. Elsevier, Amsterdam"},{"key":"3796_CR18","unstructured":"U.S. Centers for Disease Control and Prevention (2019) Antibiotic Resistance Threats in the United States, 2019. Atlanta, Georgia"},{"key":"3796_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.12465","author":"N McDerby","year":"2014","unstructured":"McDerby N, Watson SL, Robaei D, Naunton M (2014) Inappropriate use of topical chloramphenicol results in vision loss. Clin Exp Ophthalmol. https:\/\/doi.org\/10.1111\/ceo.12465","journal-title":"Clin Exp Ophthalmol"},{"key":"3796_CR20","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 372","DOI":"10.1136\/bmj.n71"},{"key":"3796_CR21","doi-asserted-by":"publisher","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, et al (2019) RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ, 366. https:\/\/doi.org\/10.1136\/bmj.l4898","DOI":"10.1136\/bmj.l4898"},{"key":"3796_CR22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/bmj.38891.551088.7C","volume":"333","author":"HA Everitt","year":"2006","unstructured":"Everitt HA, Little PS, Smith PWF (2006) A randomised controlled trial of management strategies for acute infective conjunctivitis in general practice. Br Med J 333:321\u2013324. https:\/\/doi.org\/10.1136\/bmj.38891.551088.7C","journal-title":"Br Med J"},{"key":"3796_CR23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(05)66709-8","volume":"366","author":"PW Rose","year":"2005","unstructured":"Rose PW, Harnden A, Bruggemann AB et al (2005) Chloramphenicol treatment for acute infective conjunctivitis in children in primary care: a randomised double-blind placebo-controlled trial. Lancet 366:37\u201343","journal-title":"Lancet"},{"key":"3796_CR24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1034\/j.1600-0420.2002.800212.x","volume":"80","author":"EK Normann","year":"2002","unstructured":"Normann EK, Bakken O, Peltola J et al (2002) Treatment of acute neonatal bacterial conjunctivitis: a comparison of fucidic acid to chloramphenicol eye drops. Acta Ophthalmol Scand 80:183\u2013187","journal-title":"Acta Ophthalmol Scand"},{"key":"3796_CR25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1755-3768.1993.tb04983.x","volume":"71","author":"I H\u00f8rven","year":"1993","unstructured":"H\u00f8rven I (1993) Acute conjunctivitis: a comparison of fusidic acid viscous eye drops and chloramphenicol. Acta Ophthalmol 71:165\u2013168. https:\/\/doi.org\/10.1111\/j.1755-3768.1993.tb04983.x","journal-title":"Acta Ophthalmol"},{"key":"3796_CR26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF01646112","volume":"15","author":"OP Van Bijsterveld","year":"1987","unstructured":"Van Bijsterveld OP, El Batawi Y, Sobhi FS, Nassar MW (1987) Fusidic acid in infections of the external eye. Infection 15:16\u201319","journal-title":"Infection"},{"key":"3796_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1755-3768.1987.tb08489.x","volume":"65","author":"J Hvidberg","year":"1987","unstructured":"Hvidberg J (1987) Fusidic acid in acute conjunctivitis. Acta Ophthalmol 65:43\u201347. https:\/\/doi.org\/10.1111\/j.1755-3768.1987.tb08489.x","journal-title":"Acta Ophthalmol"},{"key":"3796_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1755-3768.1987.tb06989.x","volume":"65","author":"M Dirdal","year":"1987","unstructured":"Dirdal M (1987) Fucithalmic in acute conjunctivitis. Acta Ophthalmol 65:129\u2013133. https:\/\/doi.org\/10.1111\/j.1755-3768.1987.tb06989.x","journal-title":"Acta Ophthalmol"},{"key":"3796_CR29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jac\/23.2.261","volume":"23","author":"KF Booth","year":"1989","unstructured":"Booth KF, Calthrop JG, Cox E et al (1989) Trimethoprim-polymyxin B sulphate ophthalmic ointment versos chloramphenicol ophthlmic ointment in the treatment of bacterial conjunctivitis\u2014a review of four clinical studies. J Antimicrob Chemother 23:261\u2013266","journal-title":"J Antimicrob Chemother"},{"key":"3796_CR30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1185\/03007998809114240","volume":"11","author":"W Behrens-Baumann","year":"1988","unstructured":"Behrens-Baumann W, Quentin CD, Gibson JR et al (1988) Trimethoprim-polymyxin B sulphate ophthalmic ointment in the treatment of bacterial conjunctivitis: a double-blind study versus chloramphenicol ophthalmic ointment summary. Curr Med Res Opin 11:227","journal-title":"Curr Med Res Opin"},{"key":"3796_CR31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00044011-199815040-00001","volume":"15","author":"A Agius-Fernandez","year":"1998","unstructured":"Agius-Fernandez A, Patterson A, Fsadni M et al (1998) Topical lomefloxacin versus topical chloramphenicol in the treatment of acute bacterial conjunctivitis. Clin Drug Investig 15:263\u2013269","journal-title":"Clin Drug Investig"},{"key":"3796_CR32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/eye.1992.23","volume":"6","author":"IM Miller","year":"1992","unstructured":"Miller IM, Wittreich JM, Cook T, Vogel R (1992) The safety and efficacy of topical norfloxacin compared with chloramphenicol for the treatment of external ocular bacterial infections. Eye 6:111\u2013114","journal-title":"Eye"},{"key":"3796_CR33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/112067219300300205","volume":"3","author":"WJ Power","year":"1993","unstructured":"Power WJ, Collum LMT, Easty DL et al (1993) Evaluation of efficacy and safety of ciprofloxacin ophthalmic solution versus chloramphenicol. Eur J Ophthalmol 3:77\u201382","journal-title":"Eur J Ophthalmol"},{"key":"3796_CR34","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1136\/bjo.75.11.675","volume":"75","author":"AJ Bron","year":"1991","unstructured":"Bron AJ, Leber G, Rizk SNM et al (1991) Ofloxacin compared with chloramphenicol in the management of external ocular infection. Br J Ophthalmol 75:675\u2013679","journal-title":"Br J Ophthalmol"},{"key":"3796_CR35","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/archopht.1987.01060070061029","volume":"105","author":"I Sandstr\u00f6m","year":"1987","unstructured":"Sandstr\u00f6m I (1987) Treatment of neonatal conjunctivitis. Arch Ophthalmol 105:925\u2013928","journal-title":"Arch Ophthalmol"},{"key":"3796_CR36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/archopht.1951.01700010047006","volume":"45","author":"IH Leopold","year":"1951","unstructured":"Leopold IH (1951) Clinical trial with chloramphenicol in ocular infections. AMA Arch Ophthalmol 45:44\u201352","journal-title":"AMA Arch Ophthalmol"},{"key":"3796_CR37","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/0002-9394(51)90681-2","volume":"34","author":"W Roberts","year":"1951","unstructured":"Roberts W (1951) Topical use of chloramphenicol in external ocular infections. Am J Ophthalmol 34:1081\u20131088. https:\/\/doi.org\/10.1016\/0002-9394(51)90681-2","journal-title":"Am J Ophthalmol"},{"key":"3796_CR38","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1097\/01.ico.0000263125.99262.42","volume":"21","author":"M Fukuda","year":"2002","unstructured":"Fukuda M, Ohashi H, Matsumoto C et al (2002) Methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococcus ocular surface infection. Cornea 21:586\u2013589. https:\/\/doi.org\/10.1097\/01.ico.0000263125.99262.42","journal-title":"Cornea"},{"key":"3796_CR39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/0002-9394(68)91798-4","volume":"66","author":"JV Aragones","year":"1968","unstructured":"Aragones JV, Eriksen SP (1968) Stable chloramphenicol solution for ocular infections. Am J Ophthalmol 66:104\u2013106. https:\/\/doi.org\/10.1016\/0002-9394(68)91798-4","journal-title":"Am J Ophthalmol"},{"key":"3796_CR40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/bjo.61.4.255","volume":"61","author":"S Darougar","year":"1977","unstructured":"Darougar S, Viswalingam M, Treharne JD et al (1977) Treatment of TRIC infection of the eye with rifampicin or chloramphenicol. Br J Ophthalmol 61:255\u2013259","journal-title":"Br J Ophthalmol"},{"key":"3796_CR41","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1136\/bjophthalmol-2012-302251","volume":"97","author":"R Bourkiza","year":"2013","unstructured":"Bourkiza R, Kaye S, Bunce C et al (2013) Initial treatment of Pseudomonas aeruginosa contact lens-associated keratitis with topical chloramphenicol, and effect on outcome. Br J Ophthalmol 97:429\u2013432. https:\/\/doi.org\/10.1136\/bjophthalmol-2012-302251","journal-title":"Br J Ophthalmol"},{"key":"3796_CR42","doi-asserted-by":"crossref","unstructured":"Li X-Z, Livermore DM, Nakaido H (1994) Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrob Agents Chemother 38:1732\u20131741","DOI":"10.1128\/AAC.38.8.1732"},{"key":"3796_CR43","doi-asserted-by":"publisher","unstructured":"Yunis AA (1973) Chloramphenicol-lnduced bone marrow suppression. JAMA 213(7):1183\u20131184. https:\/\/doi.org\/10.1001\/jama.1970.03170330063011","DOI":"10.1001\/jama.1970.03170330063011"},{"key":"3796_CR44","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1365-2125.1998.00773.x","volume":"46","author":"J-R Laporte","year":"1998","unstructured":"Laporte J-R, Vidal X, Ballar\u00edn E, Ib\u00e1\u00f1 L (1998) Possible association between ocular chloramphenicol and aplastic anaemia\u2014the absolute risk is very low. Br J Clin Pharmacol 46:181\u2013184","journal-title":"Br J Clin Pharmacol"},{"key":"3796_CR45","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/bmj.316.7132.666","volume":"316","author":"B-E Wiholm","year":"1998","unstructured":"Wiholm B-E, Kelly JP, Kaufman D et al (1998) Relation of aplastic anaemia to use of chloramphenicol eye drops in two international case-control studies. Br Med J 316:666","journal-title":"Br Med J"},{"key":"3796_CR46","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.316.7132.667","volume":"316","author":"T Lancaster","year":"1998","unstructured":"Lancaster T, Swart AM, Jick H (1998) Risk of serious haematological toxicity with use of chloramphenicol eye drops in a British general practice database. Br Med J 316:667","journal-title":"Br Med J"},{"key":"3796_CR47","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/1099-1557(200005\/06)9:3<215::AID-PDS497>3.0.CO;2-K","volume":"8","author":"AG Smith","year":"2000","unstructured":"Smith AG, Dovey GJ, Cartwright RA (2000) Topical chloramphenicol and the risk of acute leukaemia in adults. Pharmacoepidemiol Drug Saf 8:215\u2013219","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3796_CR48","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1136\/bjo.75.1.64-a","volume":"75","author":"I Liphshitz","year":"1991","unstructured":"Liphshitz I, Loewenstein A (1991) Anaphylactic reaction following application of chloramphenicol eye ointment. Br J Ophthalmol 75:64. https:\/\/doi.org\/10.1136\/bjo.75.1.64-a","journal-title":"Br J Ophthalmol"},{"key":"3796_CR49","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1345\/aph.18095","volume":"33","author":"R Leone","year":"1999","unstructured":"Leone R, Ghiotto E, Conforti A, Velo G (1999) Potential interaction between warfarin and ocular chloramphenicol. Ann Pharmacol 33:114","journal-title":"Ann Pharmacol"},{"key":"3796_CR50","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jama.1965.03080020064025","volume":"191","author":"RL Rosenthal","year":"1966","unstructured":"Rosenthal RL, Blackman A (1966) Bone-marrow hypoplasia following use of chloramphenicol eye drops. JAMA 191:136\u2013137","journal-title":"JAMA"},{"key":"3796_CR51","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/0002-9394(82)90540-2","volume":"93","author":"FT Fraunfelder","year":"1982","unstructured":"Fraunfelder FT, Bagby GC, Kelly DJ (1982) Fatal aplastic anemia following topical administration of ophthalmic chloramphenicol. Am J Ophthalmol 93:356\u2013360. https:\/\/doi.org\/10.1016\/0002-9394(82)90540-2","journal-title":"Am J Ophthalmol"},{"key":"3796_CR52","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0140-6736(75)92766-X","volume":"16","author":"G Carpenter","year":"1975","unstructured":"Carpenter G (1975) Chloramphenicol eye-drops and marrow aplasia. Lancet 16:326\u2013327","journal-title":"Lancet"},{"key":"3796_CR53","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/bjo.74.10.640","volume":"74","author":"TF De Sevilla","year":"1990","unstructured":"De Sevilla TF, Alegre J, Vallespi T et al (1990) Adult pure red cell aplasia following topical ocular chloramphenicol. Br J Ophthalmol 74:640","journal-title":"Br J Ophthalmol"},{"key":"3796_CR54","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/archinte.1980.00330160136049","volume":"140","author":"SM Abrams","year":"1980","unstructured":"Abrams SM, Degnan TJ, Vinciguerra V (1980) Marrow aplasia following topical application of chloramphenicol eye ointment. Arch Intern Med 140:576\u2013577","journal-title":"Arch Intern Med"},{"key":"3796_CR55","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3399\/bjgp09X473132","volume":"59","author":"H Davis","year":"2009","unstructured":"Davis H, Mant D, Scott C et al (2009) Relative impact of clinical evidence and over-the-counter prescribing on topical antibiotic use for acute infective conjunctivitis. Br J Gen Pract 59:897\u2013900. https:\/\/doi.org\/10.3399\/bjgp09X473132","journal-title":"Br J Gen Pract"},{"key":"3796_CR56","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/ijpp.18.05.00046.x","volume":"18","author":"R Walker","year":"2010","unstructured":"Walker R, Hinchliffe A (2010) Prescribing and sale of ophthalmic chloramphenicol following reclassification to over-the-counter availability. Int J Pharm Pract 18:269\u2013274","journal-title":"Int J Pharm Pract"},{"key":"3796_CR57","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/ijpp.12033","volume":"22","author":"HCT Du","year":"2014","unstructured":"Du HCT, John DN, Walker R (2014) An investigation of prescription and over-the-counter supply of ophthalmic chloramphenicol in Wales in the 5 years following reclassification. Int J Pharm Pract 22:20\u201327. https:\/\/doi.org\/10.1111\/ijpp.12033","journal-title":"Int J Pharm Pract"},{"key":"3796_CR58","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/ijpp.12119","volume":"23","author":"L Alkhatib","year":"2015","unstructured":"Alkhatib L, Parsons R, Czarniak P, Sunderland VB (2015) An evaluation of the reclassification of ophthalmic chloramphenicol for the management of acute bacterial conjunctivitis in community pharmacies in Western Australia. Int J Pharm Pract 23:111\u2013120. https:\/\/doi.org\/10.1111\/ijpp.12119","journal-title":"Int J Pharm Pract"},{"key":"3796_CR59","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.sapharm.2013.04.007","volume":"10","author":"V Paudyal","year":"2014","unstructured":"Paudyal V, Hansford D, Cunningham S, Stewart D (2014) Pharmacists\u2019 adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making. Res Social Adm Pharm 10:88\u2013105. https:\/\/doi.org\/10.1016\/j.sapharm.2013.04.007","journal-title":"Res Social Adm Pharm"},{"key":"3796_CR60","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM196506032722201","volume":"272","author":"JL Scott","year":"1965","unstructured":"Scott JL, Finegold SM, Belkin GA, Lawrence JS (1965) A controlled double-blind study of the hematologic toxicity of chloramphenicol. N Engl J Med 272:1137\u20131142","journal-title":"N Engl J Med"},{"key":"3796_CR61","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/bjo.63.10.690","volume":"63","author":"GE Trope","year":"1979","unstructured":"Trope GE, Lawrence JR, Hind VMD, Bunney J (1979) Systemic absorption of topically applied chloramphenicol eyedrops. Br J Ophthalmol 63:690\u2013691","journal-title":"Br J Ophthalmol"},{"key":"3796_CR62","unstructured":"Waiting Time for New Case Booking at Eye Specialist Out-patient Clinics. Hospital Authority. https:\/\/www.ha.org.hk\/visitor\/sopc_waiting_time.asp?id=2&lang=ENG. Accessed 17 September 2025."},{"key":"3796_CR63","unstructured":"Census and Statistics Department (2017) 2016 Population By-census: Main Results. Hong Kong"},{"key":"3796_CR64","unstructured":"Eye. Hospital Authority Drug Formulary. https:\/\/www.ha.org.hk\/hadf\/Portals\/0\/Docs\/HADF_List\/External%20list%2020190413\/11%20%20%20EYE.pdf. Accessed 17 September 2025."},{"key":"3796_CR65","unstructured":"Fees and Charges. Hospital Authority. https:\/\/www.ha.org.hk\/visitor\/ha_visitor_index.asp?Parent_ID=10044&Content_ID=10045&Ver=HTML. Accessed 17 September 2025."},{"key":"3796_CR66","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/ceo.13963","volume":"49","author":"JG Pearce","year":"2021","unstructured":"Pearce JG, Essex RW, Maddess T (2021) Topical chloramphenicol usage in Australia pre- and post-rescheduling as a non-prescription medication. Clin Exp Ophthalmol 49:762\u2013765. https:\/\/doi.org\/10.1111\/ceo.13963","journal-title":"Clin Exp Ophthalmol"},{"key":"3796_CR67","volume-title":"Australian Pharmaceutical Formulary and Handbook","author":"Pharmaceutical Society of Australia","year":"2012","unstructured":"Pharmaceutical Society of Australia (2012) Australian Pharmaceutical Formulary and Handbook, 22nd edn. Pharmaceutical Society of Australia, Canberra","edition":"22"},{"key":"3796_CR68","doi-asserted-by":"publisher","unstructured":"Wohlfarth E, Kresken M, Deuchert F (2024) Antimicrobial susceptibility of bacterial pathogens from patients with ocular surface infections in Germany, 2020\u20132021: a comparison with the data from three previous National Studies. Antibiotics 13. https:\/\/doi.org\/10.3390\/antibiotics13060471","DOI":"10.3390\/antibiotics13060471"},{"key":"3796_CR69","doi-asserted-by":"publisher","first-page":"557","DOI":"10.69605\/ijlbpr_13.8.2024.96","volume":"13","author":"A Verma","year":"2024","unstructured":"Verma A, Yadav SK, Sujatha R, Bind DS (2024) Microbiological profile of ophthalmic infections and the antibiotic susceptibility pattern of the bacterial isolates at a tertiary care hospital, Kanpur UP (India). Int J Life Sci Biotechnol Pharma Res 13:557\u2013562. https:\/\/doi.org\/10.69605\/ijlbpr_13.8.2024.96","journal-title":"Int J Life Sci Biotechnol Pharma Res"},{"key":"3796_CR70","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2024-001682","author":"TF Somerville","year":"2024","unstructured":"Somerville TF, Mdala S, Zungu T et al (2024) Microbial keratitis in Southern Malawi: a microbiological pilot study. BMJ Open Ophthalmol. https:\/\/doi.org\/10.1136\/bmjophth-2024-001682","journal-title":"BMJ Open Ophthalmol"},{"key":"3796_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-024-00417-x","author":"M Soleimani","year":"2024","unstructured":"Soleimani M, Najafabadi SJ, Razavi A et al (2024) Clinical characteristics, predisposing factors, and management of moraxella keratitis in a tertiary eye hospital. J Ophthalmic Inflamm Infect. https:\/\/doi.org\/10.1186\/s12348-024-00417-x","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"3796_CR72","doi-asserted-by":"publisher","unstructured":"Soleimani M, Baharnoori SM, Ghafarian S, et al (2024) Infectious keratitis in pediatric population aged less than two years: a tertiary eye institute experience. J Ophthalmic Inflamm Infect 14. https:\/\/doi.org\/10.1186\/s12348-024-00414-0","DOI":"10.1186\/s12348-024-00414-0"},{"key":"3796_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-024-00432-y","author":"J Roth","year":"2024","unstructured":"Roth J, Toprak B, Somajo S et al (2024) Characterization of infectious bacterial keratitis in \u00d6sterg\u00f6tland County, Sweden: a 10-year retrospective study. J Ophthalmic Inflamm Infect. https:\/\/doi.org\/10.1186\/s12348-024-00432-y","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"3796_CR74","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s00417-023-06362-0","volume":"262","author":"AA Nayel","year":"2024","unstructured":"Nayel AA, Hamdy NA, Massoud TH, Mohamed NM (2024) A comparison of antimicrobial regimen outcomes and antibiogram development in microbial keratitis: a prospective cohort study in Alexandria, Egypt. Graefe\u2019s Arch  Clin  Exp Ophthalmol 262:1865\u20131882. https:\/\/doi.org\/10.1007\/s00417-023-06362-0","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"3796_CR75","doi-asserted-by":"publisher","unstructured":"Li PP, Li L, Zhang JF, et al (2024) Five-year analysis of isolated pathogens and antibiotic resistance of ocular infections from two large tertiary comprehensive hospitals in east China. Int J Ophthalmol 17:1707\u20131716. https:\/\/doi.org\/10.18240\/ijo.2024.09.19","DOI":"10.18240\/ijo.2024.09.19"},{"key":"3796_CR76","doi-asserted-by":"publisher","unstructured":"Jia P, Qin J, Cao X, et al (2024) Clinical and pathogenic characteristics of infectious endophthalmitis in children: a retrospective analysis. Medicine 103. https:\/\/doi.org\/10.1097\/MD.0000000000038456","DOI":"10.1097\/MD.0000000000038456"},{"key":"3796_CR77","first-page":"137","volume":"47","author":"J De Ara\u00fajo","year":"2024","unstructured":"De Ara\u00fajo J, Kukla R, Vajrychov\u00e1 M et al (2024) Research on bacteria isolated from ocular infections, their antibiotic susceptibility patterns and impact on selection of appropriate therapy. New Microbiol 47:137\u2013145","journal-title":"New Microbiol"},{"key":"3796_CR78","doi-asserted-by":"publisher","unstructured":"Yang Y, Wong Y, Li Y, et al (2023) clinical features, antibiotic susceptibilities, and outcomes of endophthalmitis caused by streptococcal infection: children vs. adults. Antibiotics 12. https:\/\/doi.org\/10.3390\/antibiotics12060962","DOI":"10.3390\/antibiotics12060962"},{"key":"3796_CR79","first-page":"1589","volume":"23","author":"R-X Wang","year":"2023","unstructured":"Wang R-X, Zhang X-H, Li P et al (2023) Analysis of conjunctival sac microflora and antibiotic susceptibility testing in adolescents after wearing orthokeratology lens. Int  Eye Sci 23:1589\u20131593","journal-title":"Int Eye Sci"},{"key":"3796_CR80","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s10792-022-02450-y","volume":"43","author":"M Samudio","year":"2023","unstructured":"Samudio M, Abente S, Fari\u00f1a N et al (2023) Analysis of antibiotic resistance and genetic profile of conjunctival bacteria flora before and after cataract surgery. Int Ophthalmol 43:519\u2013530. https:\/\/doi.org\/10.1007\/s10792-022-02450-y","journal-title":"Int Ophthalmol"},{"key":"3796_CR81","first-page":"60","volume":"5","author":"B Sailaja","year":"2023","unstructured":"Sailaja B, Bhavani PG, Anand PV et al (2023) Trends of antibiotic resistance in bacterial flora in cases of bacterial keratitis in a tertiary eye care center. Int J Acad  Med  Pharma 5:60\u201366","journal-title":"Int J Acad Med Pharma"},{"key":"3796_CR82","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/bjophthalmol-2021-320203","volume":"107","author":"S Sahoo","year":"2023","unstructured":"Sahoo S, Alluri H, Mitra S et al (2023) Multidrug-resistant keratitis: challenging yet manageable. Br J Ophthalmol 107:769\u2013773. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-320203","journal-title":"Br J Ophthalmol"},{"key":"3796_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12020196","author":"H Rohana","year":"2023","unstructured":"Rohana H, Hager-Cohen A, Azrad M, Peretz A (2023) Trend of changes in chloramphenicol resistance during the years 2017\u20132020: a retrospective report from Israel. Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics12020196","journal-title":"Antibiotics"},{"key":"3796_CR84","first-page":"185","volume":"36","author":"TK Panda","year":"2023","unstructured":"Panda TK, Raghu AC, Sony S (2023) Spectral analysis of bacterial keratitis and its antibiotic sensitivity in western Odisha population. J Int Med Sci Acad 36:185\u2013189","journal-title":"J Int Med Sci Acad"},{"key":"3796_CR85","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1038\/s41433-023-02404-3","volume":"37","author":"M Moledina","year":"2023","unstructured":"Moledina M, Roberts HW, Mukherjee A et al (2023) Analysis of microbial keratitis incidence, isolates and in-vitro antimicrobial susceptibility in the East of England: a 6-year study. Eye 37:2716\u20132722. https:\/\/doi.org\/10.1038\/s41433-023-02404-3","journal-title":"Eye"},{"key":"3796_CR86","first-page":"327","volume":"15","author":"A Kumar","year":"2023","unstructured":"Kumar A (2023) Bacterial corneal ulcer and drug sensitivity. Int J Curr Pharm Rev Res 15:327\u2013332","journal-title":"Int J Curr Pharm Rev Res"},{"key":"3796_CR87","doi-asserted-by":"publisher","unstructured":"Ghita AM, Iliescu DA, Ghita AC, Ilie LA (2023) Susceptibility of ocular surface bacteria to various antibiotic agents in a Romanian ophthalmology Clinic. Diagnostics 13. https:\/\/doi.org\/10.3390\/diagnostics13223409","DOI":"10.3390\/diagnostics13223409"},{"key":"3796_CR88","doi-asserted-by":"publisher","first-page":"345","DOI":"10.5935\/0004-2749.20230050","volume":"86","author":"CS de Freitas","year":"2023","unstructured":"de Freitas CS, Mesquita MO, Sasaki MSK et al (2023) Trends in the epidemiological and microbiological profiles of infectious keratitis in Southeastern Brazil. Arq Bras Oftalmol 86:345\u2013352. https:\/\/doi.org\/10.5935\/0004-2749.20230050","journal-title":"Arq Bras Oftalmol"},{"key":"3796_CR89","first-page":"1","volume":"53","author":"J Alajbegovi\u0107-Halimi\u0107","year":"2023","unstructured":"Alajbegovi\u0107-Halimi\u0107 J, Jovanovi\u0107 N, Halimi\u0107 T (2023) Microbiological evaluation of bacterial conjunctivitis in children. Acta Med Salin 53:1\u20136","journal-title":"Acta Med Salin"},{"key":"3796_CR90","doi-asserted-by":"publisher","first-page":"765","DOI":"10.2147\/IDR.S352098","volume":"15","author":"AN Woreta","year":"2022","unstructured":"Woreta AN, Kebede HB, Tilahun Y et al (2022) Antibiotic susceptibility pattern and bacterial spectrum among patients with external eye infections at Menelik II referral hospital in Addis Ababa, Ethiopia. Infect Drug Resist 15:765\u2013779. https:\/\/doi.org\/10.2147\/IDR.S352098","journal-title":"Infect Drug Resist"},{"key":"3796_CR91","doi-asserted-by":"publisher","first-page":"171","DOI":"10.37201\/req\/128.2021","volume":"35","author":"LV Oliver","year":"2022","unstructured":"Oliver LV, Calduch PB, Rodr\u00edguez LF et al (2022) Methicillin-resistant Staphylococcus epidermidis infectious keratitis: clinical and microbiological profile. Rev Esp Quimioter 35:171\u2013177. https:\/\/doi.org\/10.37201\/req\/128.2021","journal-title":"Rev Esp Quimioter"},{"key":"3796_CR92","doi-asserted-by":"publisher","unstructured":"Kareem Rhumaid A, Alak Mahdi Al-Buhilal J, AL-Rubaey NKF, Yassen AL-Zamily K (2022) Prevalence and antibiotic susceptibility of pathogenic bacteria associated with ocular infections in adult patients. Arch Razi Inst 77:1917\u20131924. https:\/\/doi.org\/10.22092\/ARI.2022.359510.2437","DOI":"10.22092\/ARI.2022.359510.2437"},{"key":"3796_CR93","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1038\/s41433-021-01643-6","volume":"36","author":"DA Harford","year":"2022","unstructured":"Harford DA, Greenan E, Knowles SJ et al (2022) The burden of methicillin-resistant Staphylococcus aureus in the delivery of eye care. Eye 36:1368\u20131372. https:\/\/doi.org\/10.1038\/s41433-021-01643-6","journal-title":"Eye"},{"key":"3796_CR94","doi-asserted-by":"publisher","unstructured":"Das AV, Joseph J (2022) The landscape of bacterial antibiotic susceptibility in a multi-tier ophthalmology network in India: an electronic medical record driven analytics report. J Med Microbiol 71. https:\/\/doi.org\/10.1099\/jmm.0.001598","DOI":"10.1099\/jmm.0.001598"},{"key":"3796_CR95","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41433-021-01440-1","volume":"36","author":"M Cabrera-Aguas","year":"2022","unstructured":"Cabrera-Aguas M, Khoo P, George CRR et al (2022) Predisposing factors, microbiological features and outcomes of patients with clinical presumed concomitant microbial and herpes simplex keratitis. Eye 36:86\u201394. https:\/\/doi.org\/10.1038\/s41433-021-01440-1","journal-title":"Eye"},{"key":"3796_CR96","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jgar.2022.03.010","volume":"29","author":"PA Asbell","year":"2022","unstructured":"Asbell PA, Sanfilippo CM, Mah FS (2022) Antibiotic susceptibility of bacterial pathogens isolated from the aqueous and vitreous humour in the Antibiotic Resistance Monitoring in Ocular micRoorganisms (ARMOR) surveillance study: 2009\u20132020 update. J Glob Antimicrob Resist 29:236\u2013240. https:\/\/doi.org\/10.1016\/j.jgar.2022.03.010","journal-title":"J Glob Antimicrob Resist"},{"key":"3796_CR97","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.ijmmb.2022.05.007","volume":"40","author":"AR Anand","year":"2022","unstructured":"Anand AR, Harinee R, Jeyalatha MV et al (2022) Microbiological profile of canaliculitis and their antibiotic susceptibility patterns: a 11-year review at a referral eye care centre. Indian J Med Microbiol 40:378\u2013383. https:\/\/doi.org\/10.1016\/j.ijmmb.2022.05.007","journal-title":"Indian J Med Microbiol"},{"key":"3796_CR98","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.22207\/JPAM.16.3.12","volume":"16","author":"M Al-Kaffas","year":"2022","unstructured":"Al-Kaffas M, Haggag MG, Soliman SM et al (2022) Genetic identification of Pseudomonas aeruginosa virulence genes associated with keratitis in Egyptian population. J Pure Appl Microbiol 16:1714\u20131721. https:\/\/doi.org\/10.22207\/JPAM.16.3.12","journal-title":"J Pure Appl Microbiol"},{"key":"3796_CR99","doi-asserted-by":"publisher","unstructured":"Wuletaw T, Geta M, Bitew A, et al (2021) Clinical and microbiological profile of bacterial and fungal suspected corneal ulcer at university of gondar tertiary eye care and training centre, Northwest Ethiopia. J Ophthalmol. https:\/\/doi.org\/10.1155\/2021\/3940151","DOI":"10.1155\/2021\/3940151"},{"key":"3796_CR100","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.clae.2019.10.139","volume":"44","author":"AM Waleed","year":"2021","unstructured":"Waleed AM, Abu-Ismail L, Shihadah W, Janakat S (2021) Antimicrobial susceptibility of bacterial isolates from the conjunctiva, storage cases and mobile phones of university students using contact lenses. Contact Lens Anterior Eye 44:62\u201366. https:\/\/doi.org\/10.1016\/j.clae.2019.10.139","journal-title":"Contact Lens Anterior Eye"},{"key":"3796_CR101","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1038\/s41433-020-01378-w","volume":"35","author":"M Soleimani","year":"2021","unstructured":"Soleimani M, Tabatabaei SA, Masoumi A et al (2021) Infectious keratitis: trends in microbiological and antibiotic sensitivity patterns. Eye 35:3110\u20133115. https:\/\/doi.org\/10.1038\/s41433-020-01378-w","journal-title":"Eye"},{"key":"3796_CR102","first-page":"368","volume":"12","author":"J-H Shi","year":"2021","unstructured":"Shi J-H, Zhou C-Q, Liu S et al (2021) Distribution of pathogenic bacteria and analysis of drug sensitivity in acute dacryocystitis. Int Eye Sci 12:368\u2013371","journal-title":"Int Eye Sci"},{"key":"3796_CR103","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00417-020-05026-7","volume":"259","author":"H Qing","year":"2021","unstructured":"Qing H, Yang Z, Shi M et al (2021) Microbial spectrum and antibiotic sensitivity in infantile dacryocystitis. Graefes Arch Clin Exp Ophthalmol 259:1263\u20131272","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3796_CR104","doi-asserted-by":"publisher","unstructured":"Petrillo F, Pignataro D, Di Lella FM, et al (2021) Antimicrobial susceptibility patterns and resistance trends of staphylococcus aureus and coagulase-negative Staphylococci strains isolated from ocular infections. Antibiotics 10. https:\/\/doi.org\/10.3390\/antibiotics","DOI":"10.3390\/antibiotics"},{"key":"3796_CR105","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ijmmb.2020.10.005","volume":"39","author":"P Neha","year":"2021","unstructured":"Neha P, Prajna L, Gunasekaran R et al (2021) Clinical and demographic study of non-tuberculous mycobacterial ocular infections in South India. Indian J Med Microbiol 39:41\u201347. https:\/\/doi.org\/10.1016\/j.ijmmb.2020.10.005","journal-title":"Indian J Med Microbiol"},{"key":"3796_CR106","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1080\/08820538.2021.1900290","volume":"36","author":"S Mitra","year":"2021","unstructured":"Mitra S, Agarwal T, Naik A et al (2021) Post-traumatic endophthalmitis: clinico-microbiological profile, antimicrobial susceptibility and prognostic factors at a Tertiary Eye Care Centre in Eastern India. Semin Ophthalmol 36:742\u2013750. https:\/\/doi.org\/10.1080\/08820538.2021.1900290","journal-title":"Semin Ophthalmol"},{"key":"3796_CR107","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00417-020-04926-y","volume":"259","author":"CC Mamah","year":"2021","unstructured":"Mamah CC, Anyalebechi OC, Onwubiko SN et al (2021) Conjunctival bacterial flora and their antibiotic sensitivity among patients scheduled for cataract surgery in a tertiary hospital in south-east Nigeria. Graefe\u2019s Arch Clin Exp Ophthalmol 259:443\u2013448. https:\/\/doi.org\/10.1007\/s00417-020-04926-y","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"3796_CR108","unstructured":"Liu S, Zhou C-Q, Shi J-H, et al (2021) Analysis of main clinical features and pathogenic bacteria of lacrimal tracheitis. Int Eye Sc, 21."},{"key":"3796_CR109","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.2147\/IDR.S314647","volume":"14","author":"C Liu","year":"2021","unstructured":"Liu C, Ding B, Ji J et al (2021) Microbial spectrum and resistance patterns in ocular infections: a 15-year review in East China. Infect Drug Resist 14:2165\u20132171. https:\/\/doi.org\/10.2147\/IDR.S314647","journal-title":"Infect Drug Resist"},{"key":"3796_CR110","first-page":"1326","volume":"21","author":"ZK Khalil","year":"2021","unstructured":"Khalil ZK, Husain K, Al-Kamil SS (2021) Diagnostic study of some microbiological dacryocystitis with in Baghdad City patients. Medico-Legal Update 21:1326\u20131331","journal-title":"Medico-Legal Update"},{"key":"3796_CR111","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1177\/1120672119896419","volume":"31","author":"G Grandi","year":"2021","unstructured":"Grandi G, Bianco G, Boattini M et al (2021) Bacterial etiology and antimicrobial resistance trends in ocular infections: a 30-year study, Turin area, Italy. Eur J Ophthalmol 31:405\u2013414. https:\/\/doi.org\/10.1177\/1120672119896419","journal-title":"Eur J Ophthalmol"},{"key":"3796_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2333794X211019700","volume":"8","author":"SB Boadi-Kusi","year":"2021","unstructured":"Boadi-Kusi SB, Kyei S, Holdbrook S et al (2021) A study of ophthalmia neonatorum in the central reion of Ghana: causative agents and antibiotic susceptibility patterns. Glob Pediatr Health 8:1\u20137. https:\/\/doi.org\/10.1177\/2333794X211019700","journal-title":"Glob Pediatr Health"},{"key":"3796_CR113","doi-asserted-by":"publisher","unstructured":"Ayehubizu Z, Mulu W, Biadglegne F (2021) Common bacterial causes of external ocular infections, associated risk factors and antibiotic resistance among patients at ophthalmology unit of Felege Hiwot Referral Hospital, Northwest Ethiopia: a cross-sectional study. J Ophthalmic Inflamm Infect 11. https:\/\/doi.org\/10.1186\/s12348-021-00238-2","DOI":"10.1186\/s12348-021-00238-2"},{"key":"3796_CR114","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10101203","author":"M Afzal","year":"2021","unstructured":"Afzal M, Vijay AK, Stapleton F, Willcox MDP (2021) Susceptibility of ocular Staphylococcus aureus to antibiotics and multipurpose disinfecting solutions. Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics10101203","journal-title":"Antibiotics"},{"key":"3796_CR115","doi-asserted-by":"publisher","unstructured":"Watson SL, Gatus BJ, Cabrera-Aguas M, et al (2020) Bacterial ocular surveillance system (BOSS) Sydney, Australia 2017\u20132018. Communicable Diseases Intelligence 44. https:\/\/doi.org\/10.33321\/cdi.2020.44.86","DOI":"10.33321\/cdi.2020.44.86"},{"key":"3796_CR116","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-020-00227-x","author":"M Soleimani","year":"2020","unstructured":"Soleimani M, Tabatabaei SA, Mohammadi SS et al (2020) A ten-year report of microbial keratitis in pediatric population under five years in a tertiary eye center. J Ophthalmic Inflamm Infect. https:\/\/doi.org\/10.1186\/s12348-020-00227-x","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"3796_CR117","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3126\/nepjoph.v12i2.26247","volume":"12","author":"S Shrestha","year":"2020","unstructured":"Shrestha S, Manandhar A (2020) Microbiological patterns of endophthalmitis in a tertiary level hospital of Kathmandu. Nepal Nepalese J Ophthalmol 12:262\u2013269","journal-title":"Nepal Nepalese J Ophthalmol"},{"key":"3796_CR118","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s10792-020-01298-4","volume":"40","author":"S Mitra","year":"2020","unstructured":"Mitra S, Basu S, Rath S, Sahu SK (2020) Colistin resistance in Gram-negative ocular infections: prevalence, clinical outcome and antibiotic susceptibility patterns. Int Ophthalmol 40:1307\u20131317. https:\/\/doi.org\/10.1007\/s10792-020-01298-4","journal-title":"Int Ophthalmol"},{"issue":"4","key":"3796_CR119","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10384-020-00746-z","volume":"64","author":"K Matsuura","year":"2020","unstructured":"Matsuura K, Miyazaki D, Sasaki S et al (2020) Conjunctival bacterial flora and antimicrobial susceptibility in bacterial pathogens isolated prior to cataract surgery. Jpn J Ophthalmol 64(4):423\u2013428. https:\/\/doi.org\/10.1007\/s10384-020-00746-z","journal-title":"Jpn J Ophthalmol"},{"key":"3796_CR120","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/ICL.0000000000000621","volume":"46","author":"HG Khor","year":"2020","unstructured":"Khor HG, Cho I, Lee KRCK, Chieng LL (2020) Spectrum of microbial keratitis encountered in the tropics. Eye Contact Lens 46:17\u201323. https:\/\/doi.org\/10.1097\/ICL.0000000000000621","journal-title":"Eye Contact Lens"},{"key":"3796_CR121","first-page":"739","volume":"20","author":"MA Jawad","year":"2020","unstructured":"Jawad MA, Mohammed TK (2020) Stye, bacterial eye infection among the students of the Technical Medical Institute, Al-Mansour. Medico-Legal Update 20:739\u2013743","journal-title":"Medico-Legal Update"},{"key":"3796_CR122","first-page":"121","volume":"6","author":"N Hatami-Mazinani","year":"2020","unstructured":"Hatami-Mazinani N, Nejabat M, Bazargani A et al (2020) A study on the most prevalent bacterial cause of corneal ulcer and their susceptibility to five common types of ophthalmic antibiotics. Trends Pharm Sci 6:121\u2013130","journal-title":"Trends Pharm Sci"},{"key":"3796_CR123","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.37506\/mlu.v20i3.1599","volume":"20","author":"FA Hameed","year":"2020","unstructured":"Hameed FA (2020) Bacteriological study of eye infection in Baghdad City. Medico-Legal Update 20:1400\u20131405","journal-title":"Medico-Legal Update"},{"key":"3796_CR124","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.2147\/OPTH.S275067","volume":"14","author":"B Griffin","year":"2020","unstructured":"Griffin B, Walkden A, Okonkwo A et al (2020) Microbial keratitis in corneal transplants: a 12-year analysis. Clin Ophthalmol 14:3591\u20133597. https:\/\/doi.org\/10.2147\/OPTH.S275067","journal-title":"Clin Ophthalmol"},{"key":"3796_CR125","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1099\/jmm.0.001180","volume":"69","author":"H Gnanam","year":"2020","unstructured":"Gnanam H, Rajapandian SGK, Gunasekaran R et al (2020) Molecular identification of Nocardia species causing endophthalmitis using multilocus sequence analysis (MLSA): a 10-year perspective. J Med Microbiol 69:728\u2013738. https:\/\/doi.org\/10.1099\/jmm.0.001180","journal-title":"J Med Microbiol"},{"key":"3796_CR126","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1177\/1120672119854985","volume":"30","author":"A de Paula","year":"2020","unstructured":"de Paula A, Oliva G, Barraquer RI, de la Paz MF (2020) Prevalence and antibiotic susceptibility of bacteria isolated in patients affected with blepharitis in a tertiary eye centre in Spain. Eur J Ophthalmol 30:991\u2013997. https:\/\/doi.org\/10.1177\/1120672119854985","journal-title":"Eur J Ophthalmol"},{"key":"3796_CR127","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/ceo.13672","volume":"48","author":"M Cabrera-Aguas","year":"2020","unstructured":"Cabrera-Aguas M, Khoo P, George CRR et al (2020) Antimicrobial resistance trends in bacterial keratitis over 5 years in Sydney, Australia. Clin Experiment Ophthalmol 48:183\u2013191. https:\/\/doi.org\/10.1111\/ceo.13672","journal-title":"Clin Experiment Ophthalmol"},{"key":"3796_CR128","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1001\/jamaophthalmol.2020.0155","volume":"138","author":"PA Asbell","year":"2020","unstructured":"Asbell PA, Sanfilippo CM, Sahm DF, Decory HH (2020) Trends in antibiotic resistance among ocular microorganisms in the United States from 2009 to 2018. JAMA Ophthalmol 138:439\u2013450. https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.0155","journal-title":"JAMA Ophthalmol"},{"key":"3796_CR129","doi-asserted-by":"publisher","first-page":"249","DOI":"10.4103\/JOCO.JOCO_113_20","volume":"32","author":"M Acharya","year":"2020","unstructured":"Acharya M, Farooqui J, Gaba T et al (2020) Delhi infectious keratitis study: update on clinico-microbiological profile and outcomes of infectious keratitis. J Curr Ophthalmol 32:249\u2013255. https:\/\/doi.org\/10.4103\/JOCO.JOCO_113_20","journal-title":"J Curr Ophthalmol"},{"key":"3796_CR130","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/ceo.13364","volume":"47","author":"S Watson","year":"2019","unstructured":"Watson S, Cabrera-Aguas M, Khoo P et al (2019) Keratitis antimicrobial resistance surveillance program, Sydney, Australia: 2016 annual report. Clin Experiment Ophthalmol 47:20\u201325. https:\/\/doi.org\/10.1111\/ceo.13364","journal-title":"Clin Experiment Ophthalmol"},{"key":"3796_CR131","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.meegid.2019.01.031","volume":"69","author":"V Nithya","year":"2019","unstructured":"Nithya V, Rathinam S, Siva Ganesa Karthikeyan R, Lalitha P (2019) A ten year study of prevalence, antimicrobial susceptibility pattern, and genotypic characterization of Methicillin resistant Staphylococcus aureus causing ocular infections in a tertiary eye care hospital in South India. Infect Genet Evol 69:203\u2013210. https:\/\/doi.org\/10.1016\/j.meegid.2019.01.031","journal-title":"Infect Genet Evol"},{"key":"3796_CR132","doi-asserted-by":"publisher","unstructured":"Mun Y, Kim MK, Oh JY (2019) Ten-year analysis of microbiological profile and antibiotic sensitivity for bacterial keratitis in Korea. PLoS One 14. https:\/\/doi.org\/10.1371\/journal.pone.0213103","DOI":"10.1371\/journal.pone.0213103"},{"key":"3796_CR133","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.2147\/IDR.S206831","volume":"12","author":"L Lin","year":"2019","unstructured":"Lin L, Duan F, Yang Y et al (2019) Nine-year analysis of isolated pathogens and antibiotic susceptibilities of microbial keratitis from a large referral eye center in southern China. Infect Drug Resist 12:1295\u20131302. https:\/\/doi.org\/10.2147\/IDR.S206831","journal-title":"Infect Drug Resist"},{"key":"3796_CR134","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1080\/02713683.2019.1631852","volume":"44","author":"P Khoo","year":"2019","unstructured":"Khoo P, Cabrera-Aguas M, Robaei D et al (2019) Microbial keratitis and ocular surface disease: a 5-year study of the microbiology, risk factors and clinical outcomes in Sydney, Australia. Curr Eye Res 44:1195\u20131202. https:\/\/doi.org\/10.1080\/02713683.2019.1631852","journal-title":"Curr Eye Res"},{"key":"3796_CR135","doi-asserted-by":"publisher","unstructured":"K\u0142os M, Pomorska-Weso\u0142owska M, Romaniszyn D, et al (2019) Epidemiology, drug resistance, and virulence of staphylococcus aureus isolated from ocular infections in polish patients. Pol J Microbiol 68:541\u2013548. https:\/\/doi.org\/10.33073\/PJM-2019-056","DOI":"10.33073\/PJM-2019-056"},{"key":"3796_CR136","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1097\/ICO.0000000000002053","volume":"38","author":"M Green","year":"2019","unstructured":"Green M, Apel A, Stapleton F (2019) Pediatric microbial keratitis in Queensland, Australia (2005 to 2015). Cornea 38:1519\u20131523","journal-title":"Cornea"},{"key":"3796_CR137","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s10792-018-0980-5","volume":"39","author":"F Doustdar","year":"2018","unstructured":"Doustdar F, Karimi F, Abedinyfar Z et al (2018) Genetic features of Pseudomonas aeruginosa isolates associated with eye infections referred to Farabi Hospital, Tehran, Iran. Int Ophthalmol 39:1581\u20131587. https:\/\/doi.org\/10.1007\/s10792-018-0980-5","journal-title":"Int Ophthalmol"},{"key":"3796_CR138","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-019-0174-y","author":"TV Dave","year":"2019","unstructured":"Dave TV, Dave VP, Sharma S et al (2019) Infectious endophthalmitis leading to evisceration: spectrum of bacterial and fungal pathogens and antibacterial susceptibility profile. J Ophthalmic Inflamm Infect. https:\/\/doi.org\/10.1186\/s12348-019-0174-y","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"3796_CR139","first-page":"1647","volume":"69","author":"R Baig","year":"2019","unstructured":"Baig R, Mal P, Ahmed K et al (2019) Microbial profile and antibiotic susceptibility trend in postoperative endophthalmitis: a 12-year review. J Pak Med Assoc 69:1647\u20131650","journal-title":"J Pak Med Assoc"},{"key":"3796_CR140","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/INF.0000000000002206","volume":"38","author":"SJ Alter","year":"2019","unstructured":"Alter SJ, Sanfilippo CM, Asbell PA, Decory HH (2019) Antibiotic resistance among pediatric-sourced ocular pathogens: 8-year findings from the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study. Pediatr Infect Dis J 38:138\u2013145. https:\/\/doi.org\/10.1097\/INF.0000000000002206","journal-title":"Pediatr Infect Dis J"},{"key":"3796_CR141","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.2147\/OPTH.S223606","volume":"13","author":"A Almizel","year":"2019","unstructured":"Almizel A, Alsuhaibani FA, Alkaff AM et al (2019) Bacterial profile and antibiotic susceptibility pattern of bacterial keratitis at a tertiary hospital in Riyadh. Clin Ophthalmol 13:2547\u20132552. https:\/\/doi.org\/10.2147\/OPTH.S223606","journal-title":"Clin Ophthalmol"},{"key":"3796_CR142","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1136\/bjophthalmol-2017-311751","volume":"102","author":"O Spierer","year":"2018","unstructured":"Spierer O, Miller D, O\u2019Brien TP (2018) Comparative activity of antimicrobials against Pseudomonas aeruginosa, Achromobacter xylosoxidans and Stenotrophomonas maltophilia keratitis isolates. Br J Ophthalmol 102:708\u2013712. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311751","journal-title":"Br J Ophthalmol"},{"key":"3796_CR143","doi-asserted-by":"publisher","unstructured":"Khalil ZK, Hadi AM, Al-Kamil SS (2018) Determination and prevalence of bacterial and fungal keratitis among patients in Baghdad city. J Pure Appl Microbiol 12:1455\u20131463. https:\/\/doi.org\/10.22207\/JPAM.12.3.49","DOI":"10.22207\/JPAM.12.3.49"},{"key":"3796_CR144","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3928\/01913913-20170718-01","volume":"55","author":"AA Hashish","year":"2018","unstructured":"Hashish AA, Elbakary MA, Allam WA (2018) Resistant infantile bacterial conjunctivitis in Egypt: a microbiology study. J Pediatr Ophthalmol Strabismus 55:135\u2013139. https:\/\/doi.org\/10.3928\/01913913-20170718-01","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"3796_CR145","doi-asserted-by":"publisher","unstructured":"Deguchi H, Kitazawa K, Kayukawa K, et al (2018) The trend of resistance to antibiotics for ocular infection of Staphylococcus aureus, coagulase-negative staphylococci, and Corynebacterium compared with 10-years previous: a retrospective observational study. PLoS One 13. https:\/\/doi.org\/10.1371\/journal.pone.0203705","DOI":"10.1371\/journal.pone.0203705"},{"key":"3796_CR146","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-018-3705-y","author":"Y Belyhun","year":"2018","unstructured":"Belyhun Y, Moges F, Endris M et al (2018) Ocular bacterial infections and antibiotic resistance patterns in patients attending Gondar Teaching Hospital, Northwest Ethiopia. BMC Res Notes. https:\/\/doi.org\/10.1186\/s13104-018-3705-y","journal-title":"BMC Res Notes"},{"key":"3796_CR147","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.jtos.2018.07.002","volume":"16","author":"B Bagga","year":"2018","unstructured":"Bagga B, Motukupally SR, Mohamed A (2018) Microbial keratitis in Stevens-Johnson syndrome: clinical and microbiological profile. Ocul Surf 16:454\u2013457. https:\/\/doi.org\/10.1016\/j.jtos.2018.07.002","journal-title":"Ocul Surf"},{"key":"3796_CR148","doi-asserted-by":"publisher","first-page":"417","DOI":"10.6084\/m9.figshare.6865643","volume":"7","author":"PA Asbell","year":"2018","unstructured":"Asbell PA, Pandit RT, Sanfilippo CM (2018) Antibiotic resistance rates by geographic region among ocular pathogens collected during the ARMOR surveillance study. Ophthalmol Ther 7:417\u2013429. https:\/\/doi.org\/10.6084\/m9.figshare.6865643","journal-title":"Ophthalmol Ther"},{"key":"3796_CR149","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205814","author":"PA Asbell","year":"2018","unstructured":"Asbell PA, DeCory HH (2018) Antibiotic resistance among bacterial conjunctival pathogens collected in the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0205814","journal-title":"PLoS ONE"},{"key":"3796_CR150","doi-asserted-by":"crossref","unstructured":"Wong ES, Y Chow CW, Luk WK, et al (2016) A 10-year review of ocular methicillin-resistant Staphylococcus aureus infections: Epidemiology, Clinical Features, and Treatment. Cornea 36:92\u201397","DOI":"10.1097\/ICO.0000000000001048"},{"key":"3796_CR151","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/eye.2017.55","volume":"31","author":"SZ Tan","year":"2017","unstructured":"Tan SZ, Walkden A, Au L et al (2017) Twelve-year analysis of microbial keratitis trends at a UK tertiary hospital. Eye 31:1229\u20131236. https:\/\/doi.org\/10.1038\/eye.2017.55","journal-title":"Eye"},{"key":"3796_CR152","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2016-000006","volume":"1","author":"A Silvester","year":"2016","unstructured":"Silvester A, Neal T, Czanner G et al (2016) Adult bacterial conjunctivitis: resistance patterns over 12 years in patients attending a large primary eye care centre in the UK. BMJ Open Ophthalmol 1:10.1136\/bmjophth-2016-000006","journal-title":"BMJ Open Ophthalmol"},{"key":"3796_CR153","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/02713683.2016.1188118","volume":"42","author":"C Liu","year":"2017","unstructured":"Liu C, Ji J, Li S et al (2017) Microbiological isolates and antibiotic susceptibilities: a 10-year review of culture-proven endophthalmitis cases. Curr Eye Res 42:443\u2013447. https:\/\/doi.org\/10.1080\/02713683.2016.1188118","journal-title":"Curr Eye Res"},{"key":"3796_CR154","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1080\/09286586.2016.1254250","volume":"24","author":"L Lin","year":"2017","unstructured":"Lin L, Lan W, Lou B et al (2017) Genus distribution of bacteria and fungi associated with keratitis in a large eye center located in Southern China. Ophthalmic Epidemiol 24:90\u201396. https:\/\/doi.org\/10.1080\/09286586.2016.1254250","journal-title":"Ophthalmic Epidemiol"},{"key":"3796_CR155","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1136\/bjophthalmol-2016-308487","volume":"101","author":"P Lalitha","year":"2017","unstructured":"Lalitha P, Manoharan G, Karpagam R et al (2017) Trends in antibiotic resistance in bacterial keratitis isolates from South India. Br J Ophthalmol 101:108\u2013113. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-308487","journal-title":"Br J Ophthalmol"},{"key":"3796_CR156","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00417-016-3504-x","volume":"255","author":"JI Huz","year":"2017","unstructured":"Huz JI, Mukkamala K, Pagan IR et al (2017) Clinical outcomes and antibiotic susceptibilities of Staphylococcus aureus endophthalmitis. Graefe\u2019s Arch Clin Exp Ophthalmol 255:651\u2013656. https:\/\/doi.org\/10.1007\/s00417-016-3504-x","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"3796_CR157","doi-asserted-by":"publisher","unstructured":"Wang N, Huang Q, Tan YW, et al (2016) Bacterial spectrum and resistance patterns in corneal infections at a Tertiary Eye Care Center in south China. Int J Ophthalmol 9:384\u2013389. https:\/\/doi.org\/10.18240\/ijo.2016.03.10","DOI":"10.18240\/ijo.2016.03.10"},{"key":"3796_CR158","first-page":"780","volume":"27","author":"H Sreekumar","year":"2016","unstructured":"Sreekumar H, Manikandan P, Aiswariya P et al (2016) Prevalence and antimicrobial susceptibility pattern of staphylococci and streptococci causing ocular infections from a tertiary eye care hospital, South India. Biomed Res 27:780\u2013786","journal-title":"Biomed Res"},{"key":"3796_CR159","doi-asserted-by":"publisher","first-page":"433","DOI":"10.5455\/medarh.2016.70.433-436","volume":"70","author":"K Shahraki","year":"2016","unstructured":"Shahraki K, Makateb A, Shirzadi K, Khosravifard K (2016) Frequency of bacterial samples from patients with chronic acquired nasolacrimal duct obstruction. Med Arch 70:433\u2013436. https:\/\/doi.org\/10.5455\/medarh.2016.70.433-436","journal-title":"Med Arch"},{"key":"3796_CR160","first-page":"128","volume":"8","author":"PG Rai","year":"2016","unstructured":"Rai PG, Chaudhary M, Kumar Sharma A, Gautam V (2016) Direct microscopy in suppurative keratitis: a report from tertiary level hospital in Nepal. Nepalese J Ophthalmol 8:128\u2013138","journal-title":"Nepalese J Ophthalmol"},{"key":"3796_CR161","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.jcrs.2016.07.022","volume":"42","author":"V Papa","year":"2016","unstructured":"Papa V, Blanco AR, Santocono M (2016) Ocular flora and their antibiotic susceptibility in patients having cataract surgery in Italy. J Cataract Refract Surg 42:1312\u20131317. https:\/\/doi.org\/10.1016\/j.jcrs.2016.07.022","journal-title":"J Cataract Refract Surg"},{"key":"3796_CR162","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/ICL.0000000000000066","volume":"42","author":"J Faghri","year":"2016","unstructured":"Faghri J, Zandi A, Peiman A et al (2016) Study on prevalence, antibiotic susceptibility, and tuf gene sequence-based genotyping of species-level of coagulase-negative Staphylococcus isolated from keratitis caused by using soft contact lenses. Eye Contact Lens 42:115\u2013119. https:\/\/doi.org\/10.1097\/ICL.0000000000000066","journal-title":"Eye Contact Lens"},{"key":"3796_CR163","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3329\/bjms.v15i3.21452","volume":"15","author":"TJ Chandra","year":"2016","unstructured":"Chandra TJ, Satish K, Selva Raj R, Sharma YV (2016) Isolation of dacrocystitis causing bacteria among the patients of East Godavari district, Andhra Pradesh. Bangladesh J Med Sci 15:399\u2013402","journal-title":"Bangladesh J Med Sci"},{"key":"3796_CR164","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/ICO.0000000000000844","volume":"35","author":"HS Al-Dhaheri","year":"2016","unstructured":"Al-Dhaheri HS, Al-Tamimi MD, Khandekar RB et al (2016) Ocular pathogens and antibiotic sensitivity in bacterial keratitis isolates at King Khaled Eye Specialist Hospital, 2011 to 2014. Cornea 35:789\u2013794","journal-title":"Cornea"},{"key":"3796_CR165","first-page":"3207","volume":"9","author":"R Mehrdad","year":"2015","unstructured":"Mehrdad R, Dashti Anahita S, Maryam A et al (2015) Isolated microorganisms and their antibiotic sensitivity patterns of Namazi Hospital Neonatal Intensive Care Unit. J Pure Appl Microbiol 9:3207\u20133212","journal-title":"J Pure Appl Microbiol"},{"key":"3796_CR166","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1136\/bjophthalmol-2015-306749","volume":"100","author":"S Das","year":"2016","unstructured":"Das S, Rao AVS, Sahu SK, Sharma S (2016) Corynebacterium spp as causative agents of microbial keratitis. Br J Ophthalmol 100:939\u2013943. https:\/\/doi.org\/10.1136\/bjophthalmol-2015-306749","journal-title":"Br J Ophthalmol"},{"key":"3796_CR167","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3109\/02713683.2015.1045084","volume":"41","author":"CM Sanfilippo","year":"2016","unstructured":"Sanfilippo CM, Morrissey I, Janes R, Morris TW (2016) Surveillance of the activity of aminoglycosides and fluoroquinolones against ophthalmic pathogens from Europe in 2010\u20132011. Curr Eye Res 41:581\u2013589. https:\/\/doi.org\/10.3109\/02713683.2015.1045084","journal-title":"Curr Eye Res"},{"key":"3796_CR168","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.ajo.2015.07.028","volume":"160","author":"M Fernandes","year":"2015","unstructured":"Fernandes M, Vira D, Dey M et al (2015) Comparison between polymicrobial and fungal keratitis: clinical features, risk factors, and outcome. Am J Ophthalmol 160:873-881.e2. https:\/\/doi.org\/10.1016\/j.ajo.2015.07.028","journal-title":"Am J Ophthalmol"},{"key":"3796_CR169","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1001\/jamaophthalmol.2015.3888","volume":"133","author":"PA Asbell","year":"2015","unstructured":"Asbell PA, Sanfilippo CM, Pillar CM et al (2015) Antibiotic resistance among ocular pathogens in the United States five-year results from the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study. JAMA Ophthalmol 133:1445\u20131454. https:\/\/doi.org\/10.1001\/jamaophthalmol.2015.3888","journal-title":"JAMA Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03796-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-025-03796-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03796-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T19:02:24Z","timestamp":1766170944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-025-03796-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":169,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3796"],"URL":"https:\/\/doi.org\/10.1007\/s10792-025-03796-9","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"26 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is a systematic review. The London School of Hygiene and Tropical Medicine MSc Research Ethics Committee has confirmed that no ethical approval is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"452"}}